EP1830843
INDOLIDONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
Anmelder
BOEHRINGER INGELHEIM INT [DE]BOEHRINGER INGELHEIM PHARMA [DE]
Erfinder
PARK JOHN EDWARD [DE]ROTH GERALD JUERGEN [DE]HECKEL ARMIN [DE]CHAUDHARY NVEED [DE]BRANDL TRIXI [CH]DAHMANN GEORG [DE]GRAUERT MATTHIAS [DE]
Externe Quellen
Klassifikation
IPC-Klassen
A61K 31/404A61K 31/44A61K 31/445A61K 31/495A61K 31/496
CPC-Klassen
A61K 31/404A61K 31/4045A61K 31/4178A61K 31/44A61K 31/445A61K 31/454A61K 31/495A61K 31/496A61K 31/5377A61K 31/551A61K 45/06A61K 47/10A61K 47/38A61K 9/0031A61K 9/0075A61K 9/0078A61K 9/0095A61K 9/02A61K 9/08A61K 9/10A61K 9/1623A61K 9/2018A61K 9/2866A61P 43/00C07D 209/34C07D 295/155C07D 295/215C07D 401/12C07D 403/12C07D 471/04
AI: Life Sciences
warum
Boehringer Ingelheim pharma — A61K. Life Science.